Confidential Project

Project ViviCella

A clinical-stage platform company developing patented anti-VEGF therapies for high-unmet-need ophthalmology and dermatology indications.

Industry

Ophthalmology

Lead Program

VVCA-101

Funding Ask

$15M Series A

Regulatory

Phase II IND Approved

Project ViviCella — Investment Teaser Open in New Tab ↗ Download ↓

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential · Prepared by Intelligentzia Capital Management · Scroll within the frame to navigate pages

Discuss This Project

Explore Project ViviCella